![James Nathanielsz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 810 007 $ al 31/08/2026
Mr. James A. Nathanielsz is an Executive Chairman, CEO & Treasurer at Propanc Biopharma, Inc. and a Chief Executive Officer & Director at Propanc Pty Ltd. He is on the Board of Directors at Propanc Pty Ltd. Mr. Nathanielsz was previously employed as a Manager-New Products by Biota Holdings Ltd. He received his undergraduate degree from Swinburne University of Technology and a graduate degree from Swinburne University of Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PROPANC BIOPHARMA INC 17,13 % | 24/07/2026 | 600.004 ( 17,13 % ) | 810 005 $ | 31/08/2026 |
| 24/07/2026 | 1 ( 100 % ) | 1 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PROPANC BIOPHARMA, INC. | Director Ejecutivo | 15/10/2007 |
Propanc Pty Ltd.
 Propanc Pty Ltd. BiotechnologyHealth Technology Engages in cancer treatment research | Fundador | 12/10/2007 |
| Empresas | Cargo | Fin |
|---|---|---|
| BIOTA HOLDINGS LTD. | Corporate Officer/Principal | 01/10/2007 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Propanc Biopharma, Inc.
 Propanc Biopharma, Inc. BiotechnologyHealth Technology Operates as a development stage healthcare company which develops new cancer treatments for patients | Health Technology |
Biota Holdings Pty Ltd.
 Biota Holdings Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as an anti infective drug development company | Health Technology |
Swinburne University of Technology
 Swinburne University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Propanc Pty Ltd.
Propanc Pty Ltd. BiotechnologyHealth Technology Engages in cancer treatment research | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
